How to obtain bioparox back for the patients? We are waiting for voices, ideas and directions of activities... - Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market | Facebook
Direct acting antivirals (hepatitis C) risk of reactivation of hepatitis B Pharmacovigilance Units Contacts
![Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00228-019-02650-z/MediaObjects/228_2019_2650_Fig1_HTML.png)
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink
How to obtain bioparox back for the patients? We are waiting for voices, ideas and directions of activities... - Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market | Facebook
University of Dundee Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative tre
![Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1186%2Fs13063-019-3209-7/MediaObjects/13063_2019_3209_Fig1_HTML.png)
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink
![Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1007%2Fs40261-018-0684-7/MediaObjects/40261_2018_684_Fig1_HTML.png)
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink
![Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study | SpringerLink](https://media.springernature.com/w136h75/springer-static/image/art%3A10.1186%2Fs12875-019-0934-7/MediaObjects/12875_2019_934_Fig1_HTML.png)